Acetaminophen and experimental acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 18, Issue 2, 2004, Pages 121-125

  Hale, Sharon L ^a,b   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Acetaminophen; Infarct size; No reflow; Rabbit

Indexed keywords

PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE NECROSIS; HEART RATE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; BLOOD PRESSURE; CORONARY CIRCULATION; CORONARY DISEASE; HEART RATE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RABBITS;

EID: 3343018409     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000029029.90975.51     Document Type: Article

References (14)

1. Merrill G, McConnell P, VanDyke K, Powell S. Coronary and myocardial effects of acetaminophen: Protection during ischemia-reperfusion. Am J Physiol 2001;280:H2631-H2638.
2. Golfetti R, VanDyke K, Rork T, Spiler N, Merrill G. Acetaminophen in the post-ischemia reperfused myocardium. Exp Biol Med 2002;227:1031-1037.
3. Merrill GF, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol 2001;96:423-430.
4. Merrill GF. Acetaminophen and low-flow myocardial ischemia: Efficacy and antioxidant mechanisms. Am J Physiol 2002;282:H1341-H1349.
5. Coker SJ, Parratt JR, Ledingham IM, et al. Thromboxane and prostacyclin release from ischemic myocardium in relation to arrhythmias. Nature 1981;291:323-324.
6. Thiemermann C, Zacharowski K. Selective activation of E-type prostanoid (3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther 2000;87:61-67.
7. Xiao CY, Hara A, Yuhki K, et al. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: A study using mice lacking their respective receptors. Circulation 2001;104:2210-2215.
8. Friedman PL, Brown EJ, Jr, Gunther S, Alexander RW, Mudge GH, Jr, Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med 1981;305:1171-1175.
9. Position of the American Heart Association on research animal use. Circulation 1985;71:849A-850A.
10. Jenkins WL. Pharmacological aspects of analgesic drugs in animals: An overview. J AM Med Assoc 1987;191:1231-1240.
11. Bellows SD, Hale SL, Kloner RA. Acute ethanol does not protect against ischemic/reperfusion injury in rabbit myocardium. J Thrombosis Thrombolysis 1996;181-184.
12. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-13921.
13. Krenz M, Baines CP, Heusch G, Downey JM, Cohen MV. Acute alcohol-induced protection against infarction in rabbit hearts: Differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol 2001;33:2015-2022.
14. Krenz M, Baines CP, Yang XM, Heusch G, Downey JM, Cohen MV. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Mol Cell Cardiol 2001;37:601-607.